Reading File

Finding Sources

Reading File

I now have excellent foundational content from Guyton & Hall. Let me compile a comprehensive answer to all 6 questions.

Here are the answers to all 6 Pharmacology questions from your notes:

Pharma: Haemorrhagic Disorders & Haemostasis

Q1. What is Haemorrhagic Disorder? Classify it.

A haemorrhagic disorder is a condition in which there is an abnormal tendency to bleed, either spontaneously or following minor injury, due to a defect in one or more components of the haemostatic mechanism.

Classification:

A. Based on the defect:

Category	Cause	Examples
Vascular defects	Abnormality of vessel wall	Scurvy, Henoch-Schönlein purpura, hereditary telangiectasia
Platelet defects	Quantitative (thrombocytopenia) or qualitative	ITP, thrombotic thrombocytopenic purpura (TTP)
Coagulation defects	Deficiency of clotting factors	Haemophilia A (Factor VIII), Haemophilia B (Factor IX), von Willebrand disease
Mixed/Combined	Multiple components affected	DIC (Disseminated Intravascular Coagulation)

B. Inherited vs Acquired:

Inherited - Haemophilia A & B, von Willebrand disease
Acquired - Liver disease, Vitamin K deficiency, anticoagulant drugs, DIC

Q2. What is Haemostasis? What are the Different Stages of Haemostasis?

Haemostasis is the process that prevents blood loss whenever a blood vessel is severed or ruptured. It is a physiological mechanism that stops bleeding while maintaining blood in a fluid state in intact vessels.

Stages of Haemostasis (4 Stages):

Stage 1 - Vascular Constriction (Vasoconstriction)

Immediately after injury, smooth muscle in the vessel wall contracts
Results from: (1) local myogenic spasm, (2) local autacoid factors from traumatized tissues and platelets (thromboxane A2), (3) nervous reflexes
Reduces blood flow rapidly - can last minutes to hours

Stage 2 - Formation of Platelet Plug (Primary Haemostasis)

Damaged vascular surface exposes collagen fibers
Platelets adhere via von Willebrand factor (vWF) acting as a bridge between subendothelial collagen and platelet glycoprotein Ib (GpIb) receptors
Activated platelets release ADP, thromboxane A2, and platelet-activating factor (PAF)
These attract more platelets - plug is initially loose but blocks small vascular openings

Stage 3 - Blood Coagulation (Secondary Haemostasis)

A complex cascade of clotting factor reactions (intrinsic and extrinsic pathways)
Culminates in conversion of fibrinogen → fibrin threads
Fibrin reinforces and strengthens the platelet plug
Common pathway: Factor X activation → thrombin formation → fibrin clot

Stage 4 - Fibrous Tissue Growth (Clot Retraction & Repair)

Fibroblasts invade the clot over days to weeks
Fibrous tissue grows into the clot, permanently sealing the hole in the vessel wall
Eventually, the vessel may be completely healed

- Guyton and Hall Textbook of Medical Physiology

Q3. Define Petechiae and Purpura

Petechiae:

Tiny, pinpoint (1-2 mm) hemorrhagic spots on skin or mucous membranes
Caused by leakage of red blood cells through capillaries due to platelet deficiency or vascular defects
Do NOT blanch on pressure (non-blanching)
Occur when platelet count is very low (< 50,000/μL)
Classic sign of thrombocytopenia - "thousands of small hemorrhagic areas develop under the skin each day" in people with too few platelets

Purpura:

Larger (> 3 mm, up to 1 cm) areas of bleeding into the skin
Represents coalescence of multiple petechiae or larger hemorrhages
Also non-blanching
May be palpable (raised) - indicates vasculitis (e.g., Henoch-Schönlein purpura)
Or non-palpable (flat) - indicates platelet/coagulation defect

Key distinction:

	Petechiae	Purpura	Ecchymosis
Size	< 3 mm	3 mm - 1 cm	> 1 cm
Cause	Platelet/vascular	Platelet/vascular	Trauma/coagulopathy

Q4. What is Thrombocytopenia?

Thrombocytopenia is a condition defined by an abnormally low platelet (thrombocyte) count in the blood (normal: 150,000-450,000/μL; thrombocytopenia = < 150,000/μL).

Causes (Mechanisms):

1. Decreased platelet production:

Bone marrow failure (aplastic anaemia, leukemia, chemotherapy)
Vitamin B12/folate deficiency
Viral infections (HIV, EBV)

2. Increased platelet destruction:

Immune-mediated: ITP (Idiopathic Thrombocytopenic Purpura) - autoantibody-mediated platelet destruction by the reticuloendothelial system; drug-induced (e.g., quinine, heparin - HIT)
Non-immune-mediated: DIC, TTP (thrombotic thrombocytopenic purpura), hemolytic uremic syndrome (HUS), sepsis

3. Increased splenic sequestration:

Splenomegaly of any cause traps platelets in the spleen

Clinical features by platelet count:

< 100,000/μL - mild bleeding risk
< 50,000/μL - significant bleeding with minor trauma
< 20,000/μL - spontaneous bleeding, petechiae, purpura

- Henry's Clinical Diagnosis and Management by Laboratory Methods

Q5. What are the Causes of Prolonged Bleeding?

Prolonged bleeding (failure of normal haemostasis) can result from defects in any stage:

1. Vascular Causes:

Hereditary hemorrhagic telangiectasia
Vasculitis (e.g., HSP)
Vitamin C deficiency (Scurvy) - weakens vessel walls

2. Platelet Causes:

Thrombocytopenia (low platelet count) - ITP, TTP, DIC, bone marrow failure
Platelet dysfunction (normal count, abnormal function) - von Willebrand disease, aspirin/NSAIDs use, Glanzmann's thrombasthenia, Bernard-Soulier syndrome

3. Coagulation Factor Defects:

Haemophilia A - Factor VIII deficiency
Haemophilia B - Factor IX deficiency
Liver disease - reduced synthesis of most coagulation factors
Vitamin K deficiency - deficiency of Factors II, VII, IX, X
Anticoagulant drugs - warfarin, heparin

4. Excessive Fibrinolysis:

DIC - widespread clot formation consumes all clotting factors and platelets, leaving the patient unable to form new clots

Q6. What is Haemophilia?

Haemophilia is a hereditary X-linked recessive bleeding disorder caused by a deficiency or dysfunction of coagulation factors, leading to impaired secondary haemostasis (clot formation).

Types:

Type	Factor Deficiency	Inheritance	Frequency
Haemophilia A	Factor VIII	X-linked recessive	~80% of cases
Haemophilia B (Christmas disease)	Factor IX	X-linked recessive	~15% of cases
Haemophilia C	Factor XI	Autosomal recessive	Rare

Severity:

Mild: Factor level 5-40% - bleeding with major trauma/surgery
Moderate: Factor level 1-5% - bleeding with minor trauma
Severe: Factor level < 1% - spontaneous bleeding into joints (haemarthrosis), muscles, internal organs

Key features:

Affects males (females are carriers)
Prolonged PTT (partial thromboplastin time), normal PT
Classic presentation: haemarthrosis (bleeding into joints, especially knee), deep muscle hematomas, prolonged bleeding after minor cuts
Treatment: Factor VIII or IX concentrate replacement, desmopressin (DDAVP) for mild Haemophilia A

Summary Table:

Q	Topic	Key Point
Q1	Haemorrhagic disorder	Abnormal bleeding - vascular, platelet, or coagulation defect
Q2	Haemostasis	4 stages: vasoconstriction → platelet plug → coagulation → repair
Q3	Petechiae/Purpura	Pinpoint vs larger skin hemorrhages; non-blanching
Q4	Thrombocytopenia	Low platelets - decreased production, increased destruction, sequestration
Q5	Prolonged bleeding	Vascular, platelet, coagulation factor, or fibrinolysis defects
Q6	Haemophilia	X-linked recessive, Factor VIII (A) or IX (B) deficiency

This is a shared conversation. Sign in to Orris to start your own chat.